News

Bio Spectrum India
biospectrumindia. com > news > 16 > 28062 > shantha-biologics-partners-with-denmarks-novo-nordisk-for-cartridge-fill-finish-in-diabetes-and-obesity-care. html

Shantha Biologics partners with Denmark's Novo Nordisk for cartridge fill-finish in diabetes and obesity care

2+ hour, 1+ min ago  (139+ words) Bio Spectrum India Shantha Biologics partners with Denmark's Novo Nordisk for cartridge fill-finish in diabetes and obesity care July 02, 2026 | Thursday | News Shantha Biologics plans to expand further in vaccines, biologics and injectable manufacturing Dr Dhananjay Tiwary takes additional charge as…...

Symbols: btc-usd
Bio Spectrum India
biospectrumindia. com > news > 16 > 28055 > morepen-starts-commercial-supplies-under-rs-825-cr-cdmo-mandate. html

Morepen starts commercial supplies under Rs 825 Cr CDMO mandate

1+ day, 2+ hour ago  (318+ words) Bio Spectrum India Morepen starts commercial supplies under Rs 825 Cr CDMO mandate July 01, 2026 | Wednesday | News First Rs 50 crore dispatch already completed in Q1 FY2026-27 Morepen Laboratories has issued an update on its recently announced Rs 825 crore CDMO mandate. The first commercial dispatch,…...

Symbols: part-21
Bio Spectrum India
biospectrumindia. com > views > 17 > 28020 > gaps-like-limited-fast-track-approval-pathways-pricing-regulations-that-may-constrain-rd-incentives-continue-to-pose-challenges. html

Gaps like limited fast-track approval pathways, pricing regulations that may constrain R&D incentives continue to pose challenges

1+ day, 7+ hour ago  (496+ words) July 01, 2026 | Wednesday | Views | By Narayan Kulkarni What strategic factors drove the decision to expand the Peenya facility with new filtration hardware lines? The Peenya facility has established a clear roadmap for expanding its manufacturing capabilities, built on a proven track…...

Symbols: nasdaq:nthi,nyse:lly,nyse:nvo,nasdaq:regn,nasdaq:mrna,btc-usd
Bio Spectrum India
biospectrumindia. com > features > 18 > 28017 > indias-push-for-true-self-reliance-in-molecular-biology-. html

India's Push for True Self-Reliance in Molecular Biology

1+ day, 7+ hour ago  (98+ words) July 01, 2026 | Wednesday | Features | By Mansi Jamsudkar Padvekar India's molecular biology enzymes, reagents, and kits market is now recognised as one of the fastest-growing segments within the broader life sciences industry, and market estimates vary depending on methodology and scope. A…...

Symbols: bio-ai
Bio Spectrum India
biospectrumindia. com > views > 17 > 28021 > biosuppliers-must-invest-not-only-in-scientific-capability-but-also-in-green-infrastructure-and-transparent-reporting-. html

Biosuppliers must invest not only in scientific capability but also in green infrastructure and transparent reporting

1+ day, 7+ hour ago  (439+ words) July 01, 2026 | Wednesday | Views | By Mansi Jamsudkar Padvekar How has Tecan's business grown in India (in the life sciences sector) over the years? How much revenue was generated during FY25-26? How much growth is expected this year? Tecan has supported India's life…...

Symbols: 688139.ss
Bio Spectrum India
biospectrumindia. com > views > 18 > 28018 > how-mergers-and-acquisitions-spell-success-for-pharma-companies. html

How Mergers and Acquisitions Spell Success for Pharma Companies

1+ day, 7+ hour ago  (226+ words) July 01, 2026 | Wednesday | Views | By Sanjiv Das Sun Pharma's purchase of Organon shows that leading Indian pharma companies are now focussed on owning therapeutic franchises instead of just selling generics in large volumes. The goal has clearly moved from "manufacture for…...

Symbols: btc-usd
Bio Spectrum India
biospectrumindia. com > news > 66 > 28046 > redcliffe-labs-appoints-kshitiz-singh-as-chief-business-officer. html

Redcliffe Labs appoints Kshitiz Singh as Chief Business Officer

2+ day, 3+ hour ago  (340+ words) Bio Spectrum India Redcliffe Labs appoints Kshitiz Singh as Chief Business Officer June 30, 2026 | Tuesday | News Kshitiz Singh brings more than 26 years of leadership experience across diagnostics, healthcare, pharmaceuticals and consumer businesses Redcliffe Labs has announced the appointment of Kshitiz Singh…...

Symbols: nasdaq:rdhl,btc-usd
Google News
biospectrumindia. com > news > 16 > 28050 > corona-remedies-commercialises-womens-hormone-manufacturing-facility-in-ahmedabad. html

CORONA Remedies commercialises women's hormone manufacturing facility in Ahmedabad

2+ day, 36+ min ago  (165+ words) Bio Spectrum India CORONA Remedies commercialises women's hormone manufacturing facility in Ahmedabad June 30, 2026 | Tuesday | News CORONA's integrated manufacturing platform supports multiple dosage forms CORONA Remedies has announced the inauguration and commercialisation of its dedicated EU-GMP approved Hormone Manufacturing Facility at…...

Symbols: acr.ax,nasdaq:cosm
Bio Spectrum India
biospectrumindia. com > news > 115 > 28043 > iit-kharagpur-develops-climate-informed-dengue-risk-assessment-framework. html

IIT Kharagpur develops climate-informed dengue risk assessment framework

2+ day, 3+ hour ago  (394+ words) Bio Spectrum India IIT Kharagpur develops climate-informed dengue risk assessment framework June 30, 2026 | Tuesday | News Cli Med should be understood as a research and decision-support framework Researchers at the Indian Institute of Technology (IIT) Kharagpur have developed Cli Med, a climate-informed…...

Bio Spectrum India
biospectrumindia. com > news > 105 > 28045 > mrmed-establishes-physical-presence-in-guwahati. html

Mr Med establishes physical presence in Guwahati

2+ day, 3+ hour ago  (245+ words) June 30, 2026 | Tuesday | News Guwahati represents a natural" choice for Mr Med. As the primary healthcare gateway for the Northeast, the city serves patients across Assam, Meghalaya, Manipur, Mizoram, Nagaland, Tripura, and Arunachal Pradesh, states where specialty pharmacy infrastructure remains sparse....